Across the past 12 months, Inmune Bio insiders reported no open-market purchases or sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Raymond Joseph Tesi | President And Ceo | 1,554,106 | 0 | 1,554,106 | 34.1% | 16 Sep, 2024 |
| 2 | Mark William Lowdell | Chief Scientific Officer | 1,518,017 | 0 | 1,518,017 | 33.3% | 07 Jul, 2026 |
| 3 | David J Moss | Chief Executive Officer | 1,294,883 | 0 | 1,294,883 | 28.4% | 07 Jul, 2026 |
| 4 | Scott Juda | Director | 86,404 | 0 | 86,404 | 1.9% | 07 Jul, 2026 |
| 5 | Timothy J Schroeder | Director | 0 | 82,187 | 82,187 | 1.8% | 14 Jul, 2023 |
| 6 | James Kelly Ganjei | Director | 17,793 | 0 | 17,793 | 0.4% | 23 Mar, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 15 Sep, 2026 | Ronnie Duane Clark | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 15 Sep, 2026 | James Sapirstein | Director | Acquired A | 100,000 | $0.00 | $0 | 100,000 | Direct |
| 02 Jul, 2026 | David J Moss | Chief Executive Officer | Acquired M | 9,014 | $1.40 | $12.62K | 1,294,883 | Direct |
| 02 Jul, 2026 | Mark William Lowdell | Chief Scientific Officer | Acquired M | 7,211 | $1.40 | $10.10K | 1,518,017 | Direct |
| 02 Jul, 2026 | Scott Juda | Director | Acquired M | 14,801 | $1.40 | $20.72K | 86,404 | Direct |
| 02 Jul, 2026 | David J Moss | Chief Executive Officer | Disposed X | 9,014 | $0.13 | $1.13K | 9,014 | Direct |
| 02 Jul, 2026 | Scott Juda | Director | Disposed X | 14,801 | $0.13 | $1.85K | 14,802 | Direct |
| 02 Jul, 2026 | Mark William Lowdell | Chief Scientific Officer | Disposed X | 7,211 | $0.13 | $901 | 7,212 | Direct |
| 01 Dec, 2025 | James Kelly Ganjei | Director | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 01 Dec, 2025 | Scott Juda | Director | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 01 Dec, 2025 | David J Moss | Chief Executive Officer | Acquired A | 750,000 | $0.00 | $0 | 750,000 | Direct |
| 01 Dec, 2025 | Timothy J Schroeder | Director | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 01 Dec, 2025 | Marcia Allen | Director | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 01 Dec, 2025 | Cory Randall Ellspermann | Cfo | Acquired A | 300,000 | $0.00 | $0 | 300,000 | Direct |
| 01 Dec, 2025 | Mark William Lowdell | Chief Scientific Officer | Acquired A | 600,000 | $0.00 | $0 | 600,000 | Direct |
| 18 Nov, 2025 | David J Moss | Chief Executive Officer | Disposed D | 400,000 | — | — | 0 | Direct |
| 18 Nov, 2025 | Marcia Allen | Director | Disposed D | 108,000 | — | — | 0 | Direct |
| 18 Nov, 2025 | Scott Juda | Director | Disposed D | 108,000 | — | — | 0 | Direct |
| 18 Nov, 2025 | Mark William Lowdell | Chief Scientific Officer | Disposed D | 400,000 | — | — | 0 | Direct |
| 18 Nov, 2025 | Timothy J Schroeder | Director | Disposed D | 108,000 | — | — | 0 | Direct |